HuGE Literature Finder
Records 1-5
|
Establishment and application of a predictive model for gefitinib-induced severe rash based on pharmacometabolomic profiling and polymorphisms of transporters in non-small cell lung cancer.
Translational oncology 2020 Nov 14 (1): 100951. Guan Shaoxing, Chen Xi, Xin Shuang, Liu Shu, Yang Yunpeng, Fang Wenfeng, Huang Yan, Zhao Hongyun, Zhu Xia, Zhuang Wei, Wang Fei, Feng Wei, Zhang Xiaoxu, Huang Min, Wang Xueding, Zhang |
|
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).
British journal of cancer 2017 Aug . Lévi Francis, Karaboué Abdoulaye, Saffroy Raphaël, Desterke Christophe, Boige Valerie, Smith Denis, Hebbar Mohamed, Innominato Pasquale, Taieb Julien, Carvalho Carlos, Guimbaud Rosine, Focan Christian, Bouchahda Mohamed, Adam René, Ducreux Michel, Milano Gérard, Lemoine Antoinet |
|
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.
Cancer chemotherapy and pharmacology 2015 Nov . Arbitrio Mariamena, Di Martino Maria Teresa, Barbieri Vito, Agapito Giuseppe, Guzzi Pietro Hiram, Botta Cirino, Iuliano Eleonora, Scionti Francesca, Altomare Emanuela, Codispoti Stefania, Conforti Serafino, Cannataro Mario, Tassone Pierfrancesco, Tagliaferri Pierosand |
A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences.
Cancer discovery 2015 Aug 5 (8): 878-91. Hoffmann Thomas J, Van Den Eeden Stephen K, Sakoda Lori C, Jorgenson Eric, Habel Laurel A, Graff Rebecca E, Passarelli Michael N, Cario Clinton L, Emami Nima C, Chao Chun R, Ghai Nirupa R, Shan Jun, Ranatunga Dilrini K, Quesenberry Charles P, Aaronson David, Presti Joseph, Wang Zhaoming, Berndt Sonja I, Chanock Stephen J, McDonnell Shannon K, French Amy J, Schaid Daniel J, Thibodeau Stephen N, Li Qiyuan, Freedman Matthew L, Penney Kathryn L, Mucci Lorelei A, Haiman Christopher A, Henderson Brian E, Seminara Daniela, Kvale Mark N, Kwok Pui-Yan, Schaefer Catherine, Risch Neil, Witte John |
|
Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jul 15 (14): 14. Kim DH, Sriharsha L, Xu W, Kamel-Reid S, Liu X, Siminovitch K, Messner HA, Lipton JH |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: